Dominic Marasco - 15 Jul 2026 Form 4 Insider Report for MANNKIND CORP (MNKD)

Reporting relationship: Pres, Endocrine Business Unit
Issuer ticker: MNKD
Reported as of: 15 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Jul 2026, 21:47:08 UTC
Prior SEC filing: 22 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Dominic Marasco

Key filing fact

Dominic Marasco filed Form 4 for MANNKIND CORP (MNKD) on 17 Jul 2026.

Key facts

This page summarizes Dominic Marasco's Form 4 filing for MANNKIND CORP (MNKD).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 17 Jul 2026, 21:47.

Change

Previous filing in this sequence was filed on 22 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002053897 Primary reporting owner

Marasco Dominic

Relationship: Pres, Endocrine Business Unit
Address: 1 CASPER STREET, DANBURY
Signature: /s/ Dominic Marasco
Signature date: 17 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MNKD transaction

Common Stock, $0.01 Par Value

Tax liability

Transaction value
Shares: -3,623
Change %: -1%
Price: $4.09^*
Shares after: 343,398
Date: 15 Jul 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units.

Footnote F2

Includes 2,775 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2026.